MUscle Side-Effects of Atorvastatin in Coronary Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Statin Adverse Reaction
Interventions
DRUG

Atorvastatin 40mg

Oral tablet fabricated and labelled at Krageroe Tablettproduksjon AS

DRUG

Placebo Oral Tablet

Oral tablet fabricated and labelled at KrageroeTablettproduksjon AS

Trial Locations (2)

3004

Vestre Viken Trust, Drammen Hospital, Drammen

3103

Hospital of Vestfold Trust, Tønsberg

All Listed Sponsors
collaborator

The Hospital of Vestfold

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

University of Oslo

OTHER

lead

Vestre Viken Hospital Trust

OTHER

NCT03874156 - MUscle Side-Effects of Atorvastatin in Coronary Patients | Biotech Hunter | Biotech Hunter